(August 23, 2016, 12:49 PM EDT) -- TRENTON, N.J. — The New Jersey Supreme Court on Aug. 22 affirmed trial court and appellate court rulings that failure-to-warn claims involving generic versions of the heartburn drug Reglan are not...
New Jersey High Court Says Failure To Update Drug Labels Isn’t Preempted
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login